Role of zoledronic acid in the prevention and treatment of osteoporosis

Role of zoledronic acid in the prevention and treatment of osteoporosis

Agnès Räkel, Andrée Boucher, Louis-Georges Ste-MarieEndocrinology, Department of Medicine. Centre de recherche du CHUM, Université de Montréal, Montréal, QC, CanadaAbstract: Taken once a year, intravenous zoledronic acid (Zol) (Reclast&...

Full description

Bibliographic Details
Main Authors:	Räkel A, Boucher A, Ste-Marie L-G
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-03-01
Series:	Clinical Interventions in Aging
Subjects:	Zoledronic acid osteoporosis elderly.
Online Access:	https://www.dovepress.com/role-of-zoledronic-acid-in-the-prevention-and-treatment-of-osteoporosi-peer-reviewed-article-CIA

Similar Items

Once-yearly zoledronic acid in hip fracture prevention
by: Oddom Demontiero, et al.
Published: (2009-03-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

Management of osteoporosis in the aging male: Focus on zoledronic acid
by: Paul K Piper Jr, et al.
Published: (2009-06-01)

Evaluating the Clinical Efficacy of Zoledronic Acid in the Prevention and Treatment of Osteoporosis in Postmenopausal Women, Compared with Conventional Medications
by: Fatemeh Rostami-Golmohammadi, et al.
Published: (2015-02-01)

Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment
by: Fateme Rostami Golmohamdi, et al.
Published: (2016-12-01)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
by: Lin H, et al.
Published: (2021-07-01)

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
by: Jun Xie, et al.
Published: (2019-12-01)

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
by: Huang CF, et al.
Published: (2021-08-01)

Zoledronic acid induced unilateral anterior uveitis
by: Shipra Gupta, et al.
Published: (2020-01-01)

Comparative study of 99Tc-MDP and zoledronic acid in the treatment of osteoporosis
by: Ying Zhou, et al.
Published: (2020-08-01)

Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
by: Wei Lin, et al.
Published: (2021-02-01)

Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
by: Shi C, et al.
Published: (2018-05-01)

The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
by: Wang Z, et al.
Published: (2021-10-01)

Systemic sclerostin antibody treatment increases osseointegration and biomechanical competence of zoledronic-acid-coated dental implants in a rat osteoporosis model
by: P Korn, et al.
Published: (2019-05-01)

Evaluation of Patient Satisfaction, Preference and Side Effects after Annual Zoledronic Acid Infusion in Patients with Osteoporosis
by: Banu Dilek, et al.
Published: (2017-04-01)

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
by: Sun SL, et al.
Published: (2016-10-01)

Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report
by: Abdulmohsen H. Al Elq
Published: (2013-03-01)

Potential protective effect of zoledronic acid when switching from long-term therapy of osteoporosis with denosumab
by: O. V. Yakushevskaya
Published: (2021-01-01)

ZOLEDRONIC ACID ADMINISTRATION ENHANCES FRACTURE HEALING IN THE OSTEOPOROTIC FRACTURES IN OVARIECTOMIZED RABBITS
by: Cansabuncu Gokhan, et al.
Published: (2019-05-01)

Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures
by: Zhong Liu, et al.
Published: (2019-06-01)

Effect of Systemic Zoledronic Acid Dosing Regimens on Bone Regeneration in Osteoporotic Rats
by: Marwa Y. Shaheen, et al.
Published: (2021-02-01)

Qualification in the field of osteoporosis treatment in doctors working in the field of physical and rehabilitation medicine
by: L. A. Marchenkova
Published: (2021-05-01)

Zoledronic Acid in Osteoporotic Vertebral Compression Fractures Treated With Percutaneous Kyphoplasty: A Meta-Analysis
by: Peng Tian, et al.
Published: (2021-05-01)

Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
by: Aya Alsalih, et al.
Published: (2021-07-01)

THE PROPHYLAXIS OF VERTEBRAL COMPRESSION REFRACTURES USING ZOLEDRONIC ACID
by: A. Yu. Kochish, et al.
Published: (2016-11-01)

Preoperative zoledronic acid therapy prevent hungry bone syndrome in patients with primary hyperparathyroidism
by: Sabaretnam Mayilvaganan, et al.
Published: (2017-01-01)

The anti-tumour effects of zoledronic acid
by: Jamal Zekri, et al.
Published: (2014-03-01)

Zoledronic acid exacerbates inflammation through M1 macrophage polarization
by: Junya Kaneko, et al.
Published: (2018-06-01)

EFFICACY OF ZOLEDRONIC ACID IN THE PREVENTION OF BONE METASTASES IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
by: T. N. Musaev, et al.
Published: (2014-07-01)

EFFICACY OF ZOLEDRONIC ACID IN THE PREVENTION OF BONE METASTASES IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
by: T. N. Musaev, et al.
Published: (2014-07-01)

Current Clinical Practice Scenario of Osteoporosis Management in India
by: Shailesh Jhaveri, et al.
Published: (2015-09-01)

Histomorphometric Evaluation of Peri-Implant Bone Response to Intravenous Administration of Zoledronate (Zometa<sup>®</sup>) in an Osteoporotic Rat Model
by: Amani M. Basudan, et al.
Published: (2020-11-01)

Combined Use of Zoledronic Acid Augments Ursolic Acid-Induced Apoptosis in Human Osteosarcoma Cells through Enhanced Oxidative Stress and Autophagy
by: Chia-Chieh Wu, et al.
Published: (2016-11-01)

A simple RP-HPLC method for related substances of zoledronic acid in pharmaceutical products
by: L. Maheswara Reddy, et al.
Published: (2017-02-01)

The clinical characteristics, complications and treatment outcomes of patients with osteoporosis at Groote Schuur Hospital
by: Abdelfadiel, Omer Alawad Homaida
Published: (2021)

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients
by: Polyzois Makras, et al.
Published: (2021-12-01)

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
by: Ibrahim Toni, et al.
Published: (2012-11-01)